Home  >  News
Eppen_Research3_6neo_Aug26
you can get e-magazine links on WhatsApp. Click here
News
  NIH-funded study shows GLP-1 drug, semaglutide extend lifespan in older, healthy mice,   September 04, 2026
  Ono Pharma inks drug discovery partnership with Aitia in neurological diseases,   September 03, 2026
  NIH researchers identify rare antibodies with potential to combat alpha-gal syndrome,   September 03, 2026
  Rigaku and Tohoku University establish a new research institute for X-ray metrology,   August 31, 2026
  RNA breakthrough provides hope for thousands of untreatable diseases,   August 31, 2026
  Flexsys narrows 6PPD replacement to two final molecules and enters cooperative R&D pact with US Geological Survey for independent toxicity testing,   August 29, 2026
  Entod Pharma announces Project AXIOM, an India-led research programme in myopia therapeutics,   August 26, 2026
  BITS Pilani develop pharma polymer-based bioink for 3D-printed skin scaffolds and customized drug delivery,   August 25, 2026
  New manufacturing approach could help advance artificial lung devices for premature babies,   August 24, 2026
  Chai Discovery collaboration with Bristol Myers Squibb to advance AI-driven antibody discovery,   August 22, 2026
  Amplitude Therapeutics and Eli Lilly collaborate to develop trans-amplifying RNA vaccines for infectious diseases,   August 22, 2026
  Brain organoid maturation is driven by a lifelike developmental clock: Study,   August 21, 2026
  CellProthera and Alfresa Holdings sign a MoU to advance phase 3 development and future wholesale distribution of ProtheraCytes in Japan,   August 13, 2026
  Acurx Pharma announces scientific partnership with Leiden University Medical Center to advance development of Acurx's DNA polymerase IIIC inhibitor antibiotics,   August 11, 2026
  BeOne Medicines & Revolution Medicines announce clinical development and regional commercialization collaboration,   August 11, 2026
  Almirall collaborates with CrystalO for discovery and development of novel small molecules in medical dermatology,   August 11, 2026
  Evotec and Odyssey Therapeutics ink AI-enabled R&D collaboration in autoimmune and inflammatory diseases,   August 08, 2026
  Mediar Therapeutics inks collaboration and option agreement with Ono Pharma to develop novel treatments for fibro-inflammatory diseases,   August 08, 2026
  Human cancer models to accelerate research and precision therapies,   August 07, 2026
  Basilea Pharmaceutica receives additional USD 5.4 mn from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam,   August 06, 2026

 Back
 
analyticaLab_India2026
NPME-2026
cphi_korea2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram